Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.630 | 5.940 | 1.310 |
Shares | 95.370 | 95.370 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.925 | 17.660 |
Price to Book | 3.317 | 3.351 |
Price to Sales | 2.379 | 2.160 |
Price to Cash Flow | 14.355 | 14.103 |
Dividend Yield | 2.855 | 2.953 |
5 Years Earnings Growth | 18.254 | 13.523 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 32.220 | 30.761 |
Financial Services | 22.460 | 20.851 |
Consumer Defensive | 13.540 | 12.712 |
Industrials | 12.720 | 16.497 |
Basic Materials | 9.510 | 8.470 |
Consumer Cyclical | 6.850 | 5.049 |
Technology | 2.690 | 3.565 |
Number of long holdings: 35
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 9.15 | 93.80 | +0.39% | |
Roche Holding Participation | CH0012032048 | 8.77 | 285.20 | +1.57% | |
Nestle | CH0038863350 | 7.74 | 78.68 | +0.51% | |
UBS Group | CH0244767585 | 5.61 | 32.39 | -0.03% | |
Holcim | CH0012214059 | 5.28 | 91.94 | +0.90% | |
Zurich Insurance Group | CH0011075394 | 4.69 | 556.80 | -0.32% | |
ABB | CH0012221716 | 4.64 | 50.14 | -1.84% | |
Richemont | CH0210483332 | 3.89 | 177.15 | +1.43% | |
Sika | CH0418792922 | 3.79 | 234.00 | +0.95% | |
Swiss Re | CH0126881561 | 3.70 | 140.10 | -0.11% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Kapital Plus A EUR | 2.82B | 0.40 | -2.67 | 2.01 | ||
Kapital Plus P2 EUR | 2.66M | 1.06 | -2.02 | 2.69 | ||
Kapital Plus I EUR | 98.71M | 0.91 | -2.17 | 2.54 | ||
Kapital Plus P EUR | 7.57M | 0.91 | -2.17 | 2.49 | ||
DE000A2DU1Y2 | 18.49M | -0.15 | -3.20 | 1.46 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review